AstraZeneca eyes 'modest' profit from COVID-19 vaccine

Sky News

12 Nov 2021 0 shares 1 views

Sky News

Published 12 Nov 2021

Drugs firm AstraZeneca has said it plans to start earning a "modest" profit from its COVID-19 vaccine having previously sold it at cost.

AstraZeneca's pledge to poorer nations as it seeks COVID jab profits from next year

Sky News 22 Nov 2021

The chief executive of AstraZeneca (AZ) has told Sky News that the company's decision to begin seeking a modest profit from its..